105 related articles for article (PubMed ID: 19968087)
21. Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease.
Fajgenbaum DC; Kurzrock R
Immunotherapy; 2016; 8(1):17-26. PubMed ID: 26634298
[TBL] [Abstract][Full Text] [Related]
22. Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions.
Bryant-Greenwood P; Sorbara L; Filie AC; Little R; Yarchoan R; Wilson W; Raffeld M; Abati A
Mod Pathol; 2003 Feb; 16(2):145-53. PubMed ID: 12591967
[TBL] [Abstract][Full Text] [Related]
23. Castleman's disease: from basic mechanisms to molecular therapeutics.
El-Osta HE; Kurzrock R
Oncologist; 2011; 16(4):497-511. PubMed ID: 21441298
[TBL] [Abstract][Full Text] [Related]
24. Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman's disease complicated by hemophagocytic lymphohistiocytosis.
Zondag TC; Rokx C; van Lom K; van den Berg AR; Sonneveld P; Dik WA; van Doornum GJ; Lam KH; van Laar JA
Int J Hematol; 2016 Apr; 103(4):469-72. PubMed ID: 26692197
[TBL] [Abstract][Full Text] [Related]
25. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy.
van Rhee F; Stone K; Szmania S; Barlogie B; Singh Z
Clin Adv Hematol Oncol; 2010 Jul; 8(7):486-98. PubMed ID: 20864917
[TBL] [Abstract][Full Text] [Related]
26. Multicentric Castleman's disease in a child with subpectoral involvement.
Koşucu P; Ahmetoğlu A; Imamoğlu M; Cay A; Cobanoğlu U; Gümele HR
Pediatr Radiol; 2003 Aug; 33(8):570-3. PubMed ID: 12768250
[TBL] [Abstract][Full Text] [Related]
27. Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma.
Teruya-Feldstein J; Zauber P; Setsuda JE; Berman EL; Sorbara L; Raffeld M; Tosato G; Jaffe ES
Lab Invest; 1998 Dec; 78(12):1637-42. PubMed ID: 9881964
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease.
Wang X; Ye S; Xiong C; Gao J; Xiao C; Xing X
Jpn J Clin Oncol; 2011 Oct; 41(10):1221-4. PubMed ID: 21890654
[TBL] [Abstract][Full Text] [Related]
29. An unusual presentation of Castleman's disease:a case report.
Izuchukwu IS; Tourbaf K; Mahoney MC
BMC Infect Dis; 2003 Sep; 3():20. PubMed ID: 12969507
[TBL] [Abstract][Full Text] [Related]
30. Parotid localized Castleman's disease and HHV-8 infection: a case report.
Caselli E; Padovani D; Di Carlo R; Grandi E; Galvan M; Cassai E; Pastore A
Eur Arch Otorhinolaryngol; 2008 Mar; 265(3):377-80. PubMed ID: 17899145
[TBL] [Abstract][Full Text] [Related]
31. Post renal transplant Castleman's disease resolved after graft nephrectomy: a case report.
Al Otaibi T; Al Sagheir A; Ludwin D; Meyer R
Transplant Proc; 2007 May; 39(4):1276-7. PubMed ID: 17524952
[TBL] [Abstract][Full Text] [Related]
32. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
33. A case of multicentric Castleman's disease in HIV infection with the rare complication of acquired angioedema.
Fernando I; Scott G
Int J STD AIDS; 2014 Jun; 25(7):523-5. PubMed ID: 24352125
[TBL] [Abstract][Full Text] [Related]
34. Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV-8)-positive multicentric Castleman's disease and featuring a follicular growth pattern.
Dargent JL; Lespagnard L; Sirtaine N; Cantinieaux B; Li R; Hermans P
APMIS; 2007 Jul; 115(7):869-74. PubMed ID: 17614857
[TBL] [Abstract][Full Text] [Related]
35. Rare presentation of unicentric Castleman's disease in the parotid gland.
Reece B; Ord R; Papadimitriou J
J Oral Maxillofac Surg; 2012 Sep; 70(9):2114-7. PubMed ID: 22305675
[TBL] [Abstract][Full Text] [Related]
36. [Evolvement in pathogen factor and pathogenesis of Castleman's disease].
Zhang Y; Li GD; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):812-5. PubMed ID: 16545195
[No Abstract] [Full Text] [Related]
37. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
[TBL] [Abstract][Full Text] [Related]
38. Multicentric Castleman's disease in HIV infection.
Collins LS; Fowler A; Tong CY; de Ruiter A
Int J STD AIDS; 2006 Jan; 17(1):19-24; quiz 25. PubMed ID: 16409673
[TBL] [Abstract][Full Text] [Related]
39. Castleman's Disease. A Review.
Roca B
AIDS Rev; 2009; 11(1):3-7. PubMed ID: 19290029
[TBL] [Abstract][Full Text] [Related]
40. Co-Existence of Multicentric Castleman's Disease and Kaposi's Sarcoma.
Yaghoobi R; Pazyar N; Tavakoli S
Indian J Dermatol; 2015; 60(3):323. PubMed ID: 26120185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
